收藏切换
Research progress on the antitumor efficacy improvement for nanomedicine by combinatorial modification with multiligand
收藏切换
PDF
Xiao-yu ZHANG1, Song-gu WU1, Hui XU2, Jun-bo GONG1, Jin-feng XING1, Zhen-ping WEI1, *
Acta Pharmaceutica Sinica | 2024, 59(7) : 1942 - 1951
Less
收藏切换
Acta Pharmaceutica Sinica | 2024, 59(7): 1942-1951
Reviews
Research progress on the antitumor efficacy improvement for nanomedicine by combinatorial modification with multiligand
Full
Xiao-yu ZHANG1, Song-gu WU1, Hui XU2, Jun-bo GONG1, Jin-feng XING1, Zhen-ping WEI1, *
Affiliations
  • 1. School of Chemical Engineering, Tianjin University, Tianjin 300350, China
  • 2. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
Published: 2024-07-12 doi: 10.16438/j.0513-4870.2023-1306
Outline
收藏切换

After entering the body from the drug delivery site, antitumor nanomedicines need to cross a series of physiopathological barriers to reach the target site of action to effectively exert antitumor therapeutic effects. The ligand modification strategy is a classic method to enhance the efficiency of nanomedicine delivery in vivo, but the contradiction between the single ligand modification strategy, which is characterized by unity and stage, and the in vivo delivery process, which is characterized by versatility and whole-process characteristics, determines that nanomedicines modified by a single ligand alone cannot satisfy the target efficacy requirements. Therefore, the use of multiligand combinatorial modification strategies by virtue of nanomedicine surface area advantages is key to advancing the next generation of smart nanomedicines. In this paper, on the basis of summarizing and classifying the commonly used functional ligands for in vivo delivery, the advantages and research progress of multiligand combination modification of antitumor nanomedicines are discussed with special focus, and the multiligand combination modification is classified as synergistic and complementary according to the combination of the ligands, which is of great significance to ensure that antitumor nanomedicines can overcome the multiple physiopathological barriers to achieve precise delivery.

nanomedicine  /  synergistic combinatorial modification  /  complementary combinatorial modification  /  tumor delivery
Xiao-yu ZHANG, Song-gu WU, Hui XU, Jun-bo GONG, Jin-feng XING, Zhen-ping WEI. Research progress on the antitumor efficacy improvement for nanomedicine by combinatorial modification with multiligand[J]. Acta Pharmaceutica Sinica, 2024 , 59 (7) : 1942 -1951 . DOI: 10.16438/j.0513-4870.2023-1306
Year 2024 volume 59 Issue 7
PDF
194
93
Cite this Article
BibTeX
Article Info
doi: 10.16438/j.0513-4870.2023-1306
  • Receive Date:2023-11-19
  • Online Date:2025-11-26
  • Published:2024-07-12
Article Data
Affiliations
History
  • Received:2023-11-19
  • Revised:2024-04-27
Funding
Affiliations
    1. School of Chemical Engineering, Tianjin University, Tianjin 300350, China
    2. School of Pharmacy, Shenyang Pharmaceutical University, Shenyang 110016, China
References
Share
https://castjournals.cast.org.cn/joweb/yxxb/EN/10.16438/j.0513-4870.2023-1306
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数

Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)

Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT